CHINA PHARMACEUTICALS INC Increase (Decrease) in Accounts Receivable
CHINA PHARMACEUTICALS INC reported Increase (Decrease) in Accounts Receivable of $779.39 thousand for the 6-month period ending 2012-06-30, per its 10-Q/A filed 2012-08-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2012-08-27
- CHINA PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was $1.03M.
- CHINA PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was -$248.90K, a 137.64% decline year-over-year.
- CHINA PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2011-12-31 was $3.09M, a 67.17% increase year-over-year.
- CHINA PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2011-09-30 was $9.73M.
- CHINA PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2011 was $8.24M.
- CHINA PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2010 was -$9.43M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2012-06-30 | $1.03M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-27 | $779.39K 10-Q/A · filed 2012-08-27 | $3.87M derived: sum of 3 quarters · filed 2012-08-27 | $13.59M derived: sum of 4 quarters · filed 2012-08-27 | |
| 2012-03-31 | -$248.90K 10-Q · filed 2012-05-21 | $2.84M derived: sum of 2 quarters · filed 2012-05-21 | $12.57M derived: sum of 3 quarters · filed 2012-05-21 | $7.33M derived: sum of 4 quarters · filed 2012-08-27 | |
| 2011-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | $12.81M derived: sum of 2 quarters · filed 2012-05-07 | $7.58M derived: sum of 3 quarters · filed 2012-08-27 | $8.24M 10-K · filed 2012-05-07 | |
| 2011-09-30 | $9.73M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $4.49M derived: sum of 2 quarters · filed 2012-08-27 | $5.15M 10-Q · filed 2011-11-21 | $7.00M derived: sum of 4 quarters · filed 2012-08-27 | |
| 2011-06-30 | -$5.24M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-27 | -$4.58M 10-Q/A · filed 2012-08-27 | $4.58M 10-Q/A · filed 2011-09-16 | -$2.73M derived: sum of 3 quarters · filed 2012-08-27 | -$5.23M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-03-31 | $661.35K 10-Q · filed 2012-05-21 | $2.51M derived: sum of 2 quarters · filed 2012-05-21 | $2.51K derived: sum of 3 quarters · filed 2012-05-21 | ||
| 2010-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | -$658.84K derived: sum of 2 quarters · filed 2012-05-07 | -$9.43M 10-K · filed 2012-05-07 | ||
| 2010-09-30 | -$2.51M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$11.27M 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | -$8.77M 10-Q/A · filed 2012-06-20 |